✦ LIBER ✦

A comparison of the effects of pioglitazone and rosiglitazone combined with glimepiride on prothrombotic state in type 2 diabetic patients with the metabolic syndrome

✍ Scribed by Giuseppe Derosa; Arrigo F.G. Cicero; Antonio Gaddi; Pietro D. Ragonesi; Mario N. Piccinni; Elena Fogari; Sibilla Salvadeo; Leonardina Ciccarelli; Roberto Fogari

Book ID: 116405312
Publisher: Elsevier Science
Year: 2005
Tongue: English
Weight: 151 KB
Volume: 69
Category: Article
ISSN: 0168-8227
DOI: 10.1016/j.diabres.2004.10.007

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Antithrombotic Effects of Rosiglitazone-

Antithrombotic Effects of Rosiglitazone-Metformin versus Glimepiride-Metformin Combination Therapy in Patients with Type 2 Diabetes Mellitus and Metabolic Syndrome

✍ Dr. Giuseppe Derosa; Dr. Antonio V. Gaddi; Dr. Mario N. Piccinni; Dr. Leonardina 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 86 KB

Metabolic effects of telmisartan and irb

Metabolic effects of telmisartan and irbesartan in type 2 diabetic patients with metabolic syndrome treated with rosiglitazone

✍ G. Derosa; E. Fogari; A. D'Angelo; A. F. G. Cicero; S. A. T. Salvadeo; P. D. Rag 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 504 KB

Effects of rosiglitazone and pioglitazon

Effects of rosiglitazone and pioglitazone on lipoprotein metabolism in patients with Type 2 diabetes and normal lipids

✍ A. L. Brackenridge; N. Jackson; W. Jefferson; M. Stolinski; F. Shojaee-Moradie; 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 90 KB

Comparison of metabolic effects of piogl

Comparison of metabolic effects of pioglitazone, metformin, and glimepiride over 1 year in Japanese patients with newly diagnosed Type 2 diabetes

✍ T. Yamanouchi; T. Sakai; K. Igarashi; K. Ichiyanagi; H. Watanabe; T. Kawasaki 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 182 KB

Metabolic effects of pioglitazone and ro

Metabolic effects of pioglitazone and rosiglitazone in patients with diabetes and metabolic syndrome treated with glimepiride: A twelve-month, multicenter, double-blind, randomized, controlled, parallel-group trial

✍ Giuseppe Derosa; Arrigo F.G Cicero; Antonio Gaddi; Pietro D Ragonesi; Elena Foga 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 128 KB

Metformin–pioglitazone and metformin–ros

Metformin–pioglitazone and metformin–rosiglitazone effects on non-conventional cardiovascular risk factors plasma level in type 2 diabetic patients with metabolic syndrome

✍ G. Derosa; A. D'Angelo; P. D. Ragonesi; L. Ciccarelli; M. N. Piccinni; F. Pricol 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 116 KB